VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies has entered into an exclusive licensing agreement with the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences for the rights to develop products for cerebral organoid culture to serve the international research community. Cerebral organoids, or brain organoids, are three-dimensional multicellular structures that mimic brain tissue in vitro and represent a groundbreaking new way to model neurological
![]()
↧